Duloxetine reduces chemotherapy induced peripheral neuropathyBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f2199 (Published 10 April 2013) Cite this as: BMJ 2013;346:f2199
The antidepressant duloxetine is the first drug shown to reduce pain in people with peripheral neuropathy after chemotherapy with taxanes or platinums. All participants in a placebo controlled crossover trial had moderate to severe pain for at least three months after chemotherapy, mostly paclitaxel …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial